CD163 and Obesity: These results may add further explanation of our previous observation that sCD163 concentration increases with deteriorating glycemic control in BMI-matched groups of subjects with NGT, IGT, and T2DM, and the common observation that the adverse metabolic consequences of obesity vary between individuals.